CN Stock MarketDetailed Quotes
600518 Kangmei Pharmaceutical
- 2.09
- +0.06+2.96%
Market Closed Jul 12 15:00 CST
28.98BMarket Cap174.17P/E (TTM)
2.14High2.01Low2.83MlotVolume2.03Open2.03Pre Close588.01MTurnover2.08%Turnover Ratio298.57P/E (Static)13.86BShares2.3352wk High4.11P/B28.45BFloat Cap1.6852wk Low2.23Limit Up13.61BShs Float26.28Historical High1.83Limit Down6.40%Amplitude0.00Historical Low--Dividend TTM2.08Avg Price1.05MlotAsk--Div YieldTTM100Lot Size1.74MlotBid
Kangmei Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -42.33%744.68M | -29.91%1.06B | -40.41%1.19B | -37.62%1.28B | -40.98%1.29B | -37.67%1.51B | 214.63%1.99B | 190.35%2.05B | 276.72%2.19B | 337.88%2.42B |
| Transactional financial assets | -33.90%77.54K | -29.42%82.8K | --91.46K | --99.86K | -93.33%117.31K | -77.63%117.31K | ---- | ---- | --1.76M | --524.3K |
| Notes receivable and accounts receivable | 11.48%2.2B | 3.16%2.08B | 19.64%1.89B | 16.81%1.82B | 23.29%1.97B | 43.55%2.01B | -26.11%1.58B | -31.08%1.56B | -32.48%1.6B | -41.90%1.4B |
| -Notes receivable | -1.49%54.95M | -1.00%49.46M | -9.83%53.02M | -38.19%29.14M | 15.58%55.78M | 6.52%49.96M | -15.98%58.8M | 12.36%47.15M | 204.41%48.26M | 353.33%46.9M |
| -Accounts receivable | 11.86%2.14B | 3.27%2.03B | 20.78%1.84B | 18.52%1.79B | 23.53%1.92B | 44.83%1.96B | -26.45%1.52B | -31.90%1.51B | -34.07%1.55B | -43.60%1.36B |
| Other receivables (including interest and dividends) | -7.87%738.35M | -10.41%709.24M | -5.41%772.13M | -15.43%808.44M | -15.52%801.41M | -15.10%791.68M | -90.93%816.25M | -89.36%955.98M | -89.48%948.62M | -89.74%932.5M |
| -Other receivable | ---- | ---- | ---- | -15.43%808.44M | ---- | -15.10%791.68M | ---- | -89.36%955.98M | ---- | -89.74%932.5M |
| Advance payment | -11.94%156.87M | -32.48%117.93M | -8.37%146.59M | -15.17%140.22M | -5.25%178.15M | 22.86%174.66M | -38.00%159.99M | -32.65%165.3M | -24.33%188.03M | -33.26%142.16M |
| Inventories | 5.96%2.81B | -3.89%2.64B | -15.18%2.81B | -14.33%2.71B | -15.74%2.65B | -13.90%2.75B | -41.12%3.32B | -43.28%3.17B | -44.24%3.14B | -44.04%3.19B |
| Receivable financing | -72.65%12.29M | -32.71%16.3M | 191.18%6.09M | 1,832.20%22.52M | 957.21%44.94M | -34.23%24.22M | -97.40%2.09M | -97.73%1.17M | -86.70%4.25M | -29.65%36.82M |
| Other current assets | 6.25%197.59M | 55.64%187.25M | 39.64%200.94M | 38.47%189.54M | 16.73%185.96M | -22.71%120.31M | -72.26%143.89M | -74.46%136.89M | -69.15%159.31M | -69.69%155.67M |
| Total current assets | -3.76%6.86B | -7.78%6.81B | -12.40%7.02B | -13.21%6.97B | -13.48%7.12B | -10.87%7.38B | -56.13%8.01B | -56.27%8.03B | -55.27%8.23B | -55.31%8.28B |
| Non Current assets | ||||||||||
| Other equity investment | -18.67%1.13M | -17.19%1.15M | 37.33%1.37M | 39.75%1.4M | 39.12%1.39M | 39.12%1.39M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M |
| Investment real estate | 1.29%2.78B | 1.40%2.81B | 23.36%2.7B | 23.46%2.73B | 23.61%2.75B | 23.42%2.77B | -33.57%2.19B | -33.44%2.21B | -33.61%2.22B | -33.65%2.24B |
| Fixed assets | ---- | ---- | ---- | -11.07%3.63B | ---- | -10.96%3.73B | ---- | -19.68%4.09B | ---- | -47.44%4.19B |
| Constru in process | ---- | ---- | ---- | -20.68%210.01M | ---- | -18.26%215.5M | ---- | -92.00%264.75M | ---- | -83.83%263.65M |
| Productive biological assets | -10.78%700.79K | -10.50%721.96K | -16.63%743.13K | -14.25%764.3K | -11.88%785.47K | -9.50%806.63K | --891.31K | --891.31K | --891.31K | --891.31K |
| Intangible assets | -8.50%474.16M | -7.32%491.02M | -9.92%507.82M | -9.82%513M | -9.75%518.21M | -8.61%529.79M | -45.40%563.73M | -45.46%568.83M | -55.70%574.2M | -55.70%579.73M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --268.24K | -82.83%219.7K | ---- |
| Goodwill | 0.00%106.35M | 0.00%106.35M | 0.00%106.35M | 0.00%106.35M | 0.00%106.35M | 0.00%106.35M | 188.14%106.35M | 188.14%106.35M | 188.14%106.35M | 188.14%106.35M |
| Long deferred expense | -20.79%64.44M | -23.34%66.47M | -20.17%72.47M | -19.48%78.09M | -21.34%81.35M | -21.34%86.71M | -0.58%90.77M | -0.70%96.99M | 0.57%103.43M | 0.10%110.22M |
| Deferred tax assets | 6.75%102.37M | 4.66%101.48M | 59.09%98.92M | 59.63%98.59M | 56.21%95.9M | 59.78%96.97M | -72.76%62.18M | -72.62%61.77M | -75.44%61.39M | -74.81%60.69M |
| Usufruct assets | -4.34%211.46M | -6.51%217.54M | 6.81%223.53M | 4.21%229.09M | 14.55%221.06M | 24.62%232.69M | 23.25%209.29M | 44.04%219.84M | 16.89%192.97M | 4.39%186.72M |
| Other non current assets | 62.58%23.43M | 49.44%21.9M | -9.97%23.06M | -24.19%19.13M | -44.34%14.41M | -44.38%14.65M | -69.16%25.62M | -71.54%25.23M | -69.57%25.89M | -74.26%26.34M |
| Total non current assets | -4.27%7.35B | -4.03%7.47B | -0.05%7.55B | -0.31%7.62B | -0.12%7.68B | 0.19%7.78B | -42.94%7.55B | -42.81%7.64B | -46.56%7.69B | -48.07%7.77B |
| Total assets | -4.02%14.21B | -5.86%14.28B | -6.41%14.56B | -6.92%14.59B | -7.03%14.8B | -5.52%15.17B | -50.59%15.56B | -50.60%15.67B | -51.45%15.92B | -52.08%16.05B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 15.18%29.96M | 2.02%26.14M | 24.95%33.05M | -36.04%11.72M | 45.24%26.01M | 68.84%25.62M | -98.22%26.45M | -98.77%18.32M | -99.23%17.91M | -99.34%15.17M |
| Notes payable and accounts payable | 6.93%2.41B | -11.98%2.26B | 7.73%2.22B | 7.55%2.12B | 11.38%2.25B | 27.22%2.56B | -31.35%2.06B | -36.31%1.97B | -36.24%2.02B | -46.44%2.02B |
| -Notes payable | 155.06%89.89M | 68.85%51.33M | --48.83M | --36.67M | --35.24M | --30.4M | ---- | ---- | ---- | ---- |
| -Accounts payable | 4.58%2.32B | -12.95%2.21B | 5.36%2.17B | 5.69%2.08B | 9.63%2.22B | 25.71%2.53B | -31.35%2.06B | -36.31%1.97B | -36.24%2.02B | -46.44%2.02B |
| Contract liabilities | -26.51%143.82M | 1.12%159.89M | -14.74%195.23M | 1.12%198.86M | 2.62%195.72M | -18.43%158.12M | -46.02%228.98M | -57.88%196.66M | -56.57%190.71M | -57.41%193.85M |
| Advance receipts | -35.94%40.55M | 4.21%58.65M | -7.65%66.47M | -7.64%65.85M | -21.56%63.31M | -15.52%56.28M | 27.98%71.98M | 34.64%71.29M | 12.96%80.7M | 9.32%66.63M |
| Salaries payable | -61.04%67.83M | -57.80%76.48M | -11.83%164.91M | -10.39%171.16M | -9.49%174.08M | -8.34%181.21M | -16.35%187.03M | -13.15%191M | -10.03%192.33M | -5.92%197.7M |
| Taxs payable | -58.69%406.88M | -42.79%571.3M | 12.72%963.71M | 9.79%962.66M | -2.50%984.88M | -1.78%998.55M | 89.98%854.93M | 94.56%876.83M | 112.32%1.01B | 112.83%1.02B |
| Other payable (including interest and dividends) | 5.36%1.41B | 5.54%1.4B | 12.38%1.38B | 11.18%1.37B | 10.66%1.34B | 7.51%1.33B | -70.28%1.23B | -70.30%1.23B | -70.60%1.21B | -66.73%1.24B |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --40.73K |
| -Other payable | ---- | ---- | ---- | 11.18%1.37B | ---- | 7.51%1.33B | ---- | -48.02%1.23B | ---- | -48.33%1.24B |
| Non current liabilities due within one year | 3.41%39.4M | 4.08%40.71M | 39.57%40.9M | 29.98%40.02M | 19.89%38.1M | 6.03%39.12M | -99.80%29.3M | -99.79%30.79M | -99.66%31.78M | -99.61%36.89M |
| Other current liabilities | -2.25%83.4M | -2.77%85.88M | -88.32%89.3M | -44.52%89.51M | -47.82%85.32M | -47.03%88.32M | -73.81%764.37M | -94.47%161.35M | -94.39%163.5M | -94.31%166.73M |
| Total current liabilities | -10.23%4.63B | -13.99%4.68B | -5.48%5.15B | 5.90%5.02B | 4.87%5.16B | 10.01%5.44B | -79.92%5.45B | -82.61%4.74B | -78.77%4.92B | -78.79%4.95B |
| Current liabilities | ||||||||||
| Long term account payable | ---- | ---- | ---- | 195.44%841.01M | ---- | 191.43%853.96M | ---- | --284.66M | ---- | --293.02M |
| Estimate liabilities | -15.04%832.44M | -12.76%855.54M | --894.27M | --970.78M | --979.81M | --980.63M | ---- | ---- | ---- | ---- |
| Deferred tax liabilities | -7.88%50.66M | -6.93%51.68M | --55.69M | --57.06M | --54.99M | --55.53M | ---- | ---- | ---- | ---- |
| Long term deferred income | -5.43%610.9M | -5.40%618.68M | -5.66%629.6M | -5.57%637.46M | -5.50%645.98M | -5.63%653.98M | -32.20%667.34M | -31.98%675.06M | -33.37%683.56M | -32.99%692.97M |
| Lease liabilities | -1.59%186.62M | -5.51%188.16M | 3.64%195.86M | 1.77%199.68M | 12.78%189.63M | 29.96%199.13M | 11.91%188.98M | 27.94%196.2M | 1.27%168.15M | 8.94%153.22M |
| Total non current liabilities | -8.36%2.49B | -8.14%2.52B | 148.30%2.58B | 134.10%2.71B | 137.01%2.71B | 140.80%2.74B | -93.41%1.04B | -92.67%1.16B | -94.45%1.14B | -94.47%1.14B |
| Total liabilities | -9.59%7.12B | -12.03%7.2B | 19.16%7.73B | 31.01%7.73B | 29.82%7.87B | 34.49%8.18B | -84.88%6.49B | -86.29%5.9B | -86.15%6.06B | -86.14%6.09B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%13.86B | 0.00%13.86B | 0.00%13.86B | 0.00%13.86B | 0.00%13.86B | 0.00%13.86B | 178.73%13.86B | 178.73%13.86B | 178.73%13.86B | 178.73%13.86B |
| Capital reserve funds | 0.00%18.78B | 0.00%18.78B | 0.00%18.78B | 0.00%18.78B | 0.00%18.78B | 0.00%18.78B | 62.26%18.78B | 62.26%18.78B | 62.26%18.78B | 62.26%18.78B |
| Surplus reserve funds | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B | 0.00%1.53B |
| Retained profit | 0.62%-25.89B | 0.39%-25.9B | -8.06%-26.15B | -11.13%-26.13B | -11.21%-26.05B | -11.53%-26B | 24.93%-24.2B | 26.85%-23.51B | 26.35%-23.43B | 25.35%-23.32B |
| Less:Treasury stock | 0.24%1.23B | 0.26%1.23B | 29.81%1.22B | 30.67%1.22B | 31.01%1.22B | 30.99%1.22B | 173.85%940.95M | 171.48%932.82M | 171.48%932.82M | 171.48%932.82M |
| Other composite income | -190.09%-121.82K | -173.69%-100.05K | 146.61%122.37K | 154.89%144.31K | 150.94%135.23K | 151.15%135.77K | 92.67%-262.52K | 92.65%-262.93K | 92.62%-265.45K | 92.90%-265.45K |
| Specific reserves | -6.80%1.21M | -1.35%1.28M | -65.76%1.15M | -65.02%1.18M | -61.51%1.3M | -61.51%1.3M | --3.36M | --3.37M | --3.37M | --3.37M |
| Shareholders equity without minority interests | 2.28%7.05B | 1.43%7.05B | -24.71%6.8B | -29.86%6.83B | -29.72%6.9B | -30.00%6.95B | 178.26%9.03B | 185.01%9.73B | 188.33%9.82B | 194.21%9.93B |
| Minority interests | 5.72%34.33M | -7.16%32.89M | -20.30%33.3M | -22.42%32.63M | -22.27%32.48M | -15.48%35.43M | -68.94%41.79M | -68.60%42.05M | -66.56%41.78M | -66.86%41.92M |
| Total shareholder equity | 2.29%7.09B | 1.38%7.08B | -24.69%6.83B | -29.83%6.86B | -29.69%6.93B | -29.94%6.98B | 179.55%9.07B | 186.39%9.77B | 189.71%9.86B | 195.76%9.97B |
| Total liabilityies and equity | -4.02%14.21B | -5.86%14.28B | -6.41%14.56B | -6.92%14.59B | -7.03%14.8B | -5.52%15.17B | -50.59%15.56B | -50.60%15.67B | -51.45%15.92B | -52.08%16.05B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes |
| Auditor | -- | Tianzhu International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianzhu International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianzhu International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg